1 November 2024 false No description of principal activity Taxfiler 2024.6 7631998 business:PrivateLimitedCompanyLtd 2024-11-01 2025-10-31 7631998 2024-10-31 7631998 2024-11-01 2025-10-31 7631998 business:AuditExempt-NoAccountantsReport 2024-11-01 2025-10-31 7631998 business:FilletedAccounts 2024-11-01 2025-10-31 7631998 2025-10-31 7631998 business:Director1 2024-11-01 2025-10-31 7631998 business:Director2 2024-11-01 2025-10-31 7631998 business:CompanySecretary1 2024-11-01 2025-10-31 7631998 business:RegisteredOffice 2024-11-01 2025-10-31 7631998 2024-10-31 7631998 core:WithinOneYear 2025-10-31 7631998 core:WithinOneYear 2024-10-31 7631998 core:AfterOneYear 2025-10-31 7631998 core:AfterOneYear 2024-10-31 7631998 core:ShareCapital core:PreviouslyStatedAmount 2025-10-31 7631998 core:ShareCapital core:PreviouslyStatedAmount 2024-10-31 7631998 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2025-10-31 7631998 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2024-10-31 7631998 core:PreviouslyStatedAmount 2025-10-31 7631998 core:PreviouslyStatedAmount 2024-10-31 7631998 business:SmallEntities 2024-11-01 2025-10-31 7631998 countries:EnglandWales 2024-11-01 2025-10-31 7631998 core:PlantMachinery 2024-11-01 2025-10-31 7631998 core:FurnitureFittings 2024-11-01 2025-10-31 7631998 core:IntangibleAssetsOtherThanGoodwill 2024-10-31 7631998 core:IntangibleAssetsOtherThanGoodwill 2025-10-31 7631998 core:IntangibleAssetsOtherThanGoodwill 2024-11-01 2025-10-31 7631998 core:PlantMachinery 2024-10-31 7631998 core:FurnitureFittings 2024-10-31 7631998 core:PlantMachinery 2025-10-31 7631998 core:FurnitureFittings 2025-10-31 7631998 core:OtherProvisionsContingentLiabilities 2024-10-31 7631998 core:OtherProvisionsContingentLiabilities 2024-11-01 2025-10-31 7631998 core:OtherProvisionsContingentLiabilities 2025-10-31 7631998 business:OrdinaryShareClass1 2024-11-01 2025-10-31 7631998 business:OrdinaryShareClass1 2023-11-01 2024-10-31 7631998 business:OrdinaryShareClass2 2024-11-01 2025-10-31 7631998 business:OrdinaryShareClass2 2023-11-01 2024-10-31 7631998 business:OrdinaryShareClass3 2024-11-01 2025-10-31 7631998 business:OrdinaryShareClass3 2023-11-01 2024-10-31 7631998 business:OrdinaryShareClass4 2024-11-01 2025-10-31 7631998 business:OrdinaryShareClass4 2023-11-01 2024-10-31 7631998 business:AllOrdinaryShares 2024-11-01 2025-10-31 7631998 business:AllOrdinaryShares 2023-11-01 2024-10-31 7631998 core:BetweenOneFiveYears 2025-10-31 7631998 core:BetweenOneFiveYears 2024-10-31 7631998 2023-11-01 2024-10-31 iso4217:GBP xbrli:shares xbrli:pure
Company Registration No. 7631998 (England and Wales)
Malpapharm Ltd Unaudited accounts for the year ended 31 October 2025
Malpapharm Ltd Unaudited accounts Contents
Page
Company information
3
Statement of financial position
4
Notes to the accounts
5
- 2 -
Malpapharm Ltd Company Information for the year ended 31 October 2025
Directors
Mr Malcolm Brown Mr Max Doyle
Secretary
Malcolm Brown
Company Number
7631998 (England and Wales)
Registered Office
117 Atwood Road Didsbury Manchester M20 6JW
Accountants
Rebecca Williams Accountants Limited 62 Derbyshire Road Sale M33 3EL
- 3 -
Malpapharm Ltd Statement of financial position as at 31 October 2025
2025
2024
Notes
£
£
Fixed assets
Intangible assets
4
59,265
118,532
Tangible assets
5
288,569
264,509
347,834
383,041
Current assets
Inventories
70,569
73,686
Debtors
6
634,561
621,452
Cash at bank and in hand
170,139
187,986
875,269
883,124
Creditors: amounts falling due within one year
7
(541,875)
(512,117)
Net current assets
333,394
371,007
Total assets less current liabilities
681,228
754,048
Creditors: amounts falling due after more than one year
8
(299,815)
(392,380)
Provisions for liabilities
Other provisions
9
-
(7,000)
Net assets
381,413
354,668
Capital and reserves
Called up share capital
10
2
2
Profit and loss account
381,411
354,666
Shareholders' funds
381,413
354,668
For the year ending 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 15 July 2026 and were signed on its behalf by
Mr Malcolm Brown Director Company Registration No. 7631998
- 4 -
Malpapharm Ltd Notes to the Accounts for the year ended 31 October 2025
1
Statutory information
Malpapharm Ltd is a private company, limited by shares, registered in England and Wales, registration number 7631998. The registered office is 117 Atwood Road, Didsbury, Manchester, M20 6JW.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention.
Turnover
Turnover represents the value, net of VAT and discounts, of goods provided to customers and work carried out in respect of services provided to customers.
Tangible fixed assets policy
Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Plant & machinery
5-20 years straight line
Fixtures & fittings
10 years straight line
Intangible fixed assets
Intangible fixed assets are included at cost less accumulated amortisation. Amortisation is charged on a straight line basis over 5 years.
4
Intangible fixed assets
Other
£
Cost
At 1 November 2024
296,333
At 31 October 2025
296,333
Amortisation
At 1 November 2024
177,801
Charge for the year
59,267
At 31 October 2025
237,068
Net book value
At 31 October 2025
59,265
At 31 October 2024
118,532
- 5 -
Malpapharm Ltd Notes to the Accounts for the year ended 31 October 2025
5
Tangible fixed assets
Plant & machinery
Fixtures & fittings
Total
£
£
£
Cost or valuation
At cost
At cost
At 1 November 2024
288,157
147,357
435,514
Additions
8,453
36,458
44,911
At 31 October 2025
296,610
183,815
480,425
Depreciation
At 1 November 2024
30,752
140,253
171,005
Charge for the year
19,316
1,535
20,851
At 31 October 2025
50,068
141,788
191,856
Net book value
At 31 October 2025
246,542
42,027
288,569
At 31 October 2024
257,405
7,104
264,509
6
Debtors
2025
2024
£
£
Amounts falling due within one year
VAT
35,905
34,082
Trade debtors
314,877
274,334
Other debtors
10,207
7,528
360,989
315,944
Amounts falling due after more than one year
Amounts due from group undertakings etc.
273,572
305,508
7
Creditors: amounts falling due within one year
2025
2024
£
£
Bank loans and overdrafts
64,834
61,441
Trade creditors
365,047
379,446
Taxes and social security
98,564
49,027
Other creditors
1,697
1,093
Loans from directors
9,973
17,851
Accruals
1,760
3,259
541,875
512,117
8
Creditors: amounts falling due after more than one year
2025
2024
£
£
Bank loans
299,815
392,380
- 6 -
Malpapharm Ltd Notes to the Accounts for the year ended 31 October 2025
9
Provisions for liabilities
£
At 1 November 2024
7,000
Provisions used
(7,000)
At 31 October 2025
-
The provision represents dilapidation costs that have now been agreed and paid during the year
10
Share capital
2025
2024
£
£
Allotted, called up and fully paid:
197 Ordinary shares of £0.01 each
1.97
1.97
1 A Ordinary shares of £0.01 each
0.01
0.01
1 B Ordinary shares of £0.01 each
0.01
0.01
1 C Ordinary shares of £0.01 each
0.01
0.01
2.00
2.00
11
Operating lease commitments
2025
2024
£
£
At 31 October 2025 the company had the following future minimum lease payments under non-cancellable operating leases for each of the following periods:
Not later than one year
33,813
8,890
Later than one year and not later than five years
41,819
25,187
75,632
34,077
12
Transactions with related parties
Group Transactions Malpapharm Holdings Limited owed Malpapharm Limited £273,572 at 31 October 2025 (2024: £305,508). No interest has been charged on this loan. Directors Transactions Total directors remuneration for the year was £69,851 (2024: £74,092) At the year end, Max Doyle had loaned £9,973 to the company (maximum during the year of £15,144). The loan is unsecured, interest free and repayable on demand. No other transactions with directors or persons connected with them require disclosure
13
Controlling party
Malpapharm Holdings Limited has a 90% shareholding in Malpapharm Limited
14
Average number of employees
During the year the average number of employees was 38 (2024: 34).
- 7 -